GC-TOF/MS-based metapolomic profiling of estrogen deficiency-induced obesity in ovariectomized rats

Acta Pharmacologica Sinica

Volumn 32, Issue 2, 2011, Pages 270-278

  Ma, Bo ^a,b   Zhang, Qi ^b   Wang, Guang Ji ^a   A, Ji Ye ^a   Wu, Di ^c   Liu, Ying ^b   Cao, Bei ^a   Liu, Lin Sheng ^a   Hu, Ying Ying ^b   Wang, Yong Lu ^b   Zheng, Ya Ya ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NANJING TECH UNIVERSITY   (China)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

estrogen deficiency; gas chromatography coupled a time of flight mass analyzer; metabolomics; obesity

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; CYSTINE; ESTROGEN; GLUCOSE; GLUTAMIC ACID; GLYCEROL; GLYCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENERGY METABOLISM; ESTROGEN DEFICIENCY; FEMALE; GAS CHROMATOGRAPHY; GLUCOSE METABOLISM; LIPID METABOLISM; METABOLOMICS; NONHUMAN; OBESITY; OVARIECTOMY; RAT; TIME OF FLIGHT MASS SPECTROMETRY;

AMINO ACIDS; ANIMALS; DISCRIMINANT ANALYSIS; DISEASE MODELS, ANIMAL; ESTROGENS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GLUCOSE; LEAST-SQUARES ANALYSIS; LIPID METABOLISM; METABOLOMICS; MULTIVARIATE ANALYSIS; OBESITY; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79551661969     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.196     Document Type: Article

References (52)

1. Haslam DW, James WP. Obesity. Lancet 2005; 366: 1197-209.
2. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 2002; 25: 127-33.
3. Burke GL, Bertoni AG, Shea S, Tracy R, Watson KE, Blumenthal RS, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 2008; 168: 928-35.
4. Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008; 39: 3145-51.
5. Kirschner MA, Ertel N, Schneider G. Obesity, hormones, and cancer. Cancer Res 1981; 41: 3711-7.
6. Cleary MP, Grossmann ME, Ray A. Effect of obesity on breast cancer development. Vet Pathol 2010; 47: 202-13.
7. Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: the estrogen connection. Endocrinology 2009; 150: 2537-42.
8. Kuhl H. Breast cancer risk in the WHI study: the problem of obesity. Maturitas 2005; 51: 83-97.
9. Balog J. Obesity and estrogen. Am J Obstet Gynecol 1978; 130: 242.
10. de Paz I P, Alameda HC, Olivar RJ. Obesity and menopause. Nutr Hosp 2006; 21: 633-7.
11. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, et al. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol 2003; 158: 1161-70.
12. Chang CJ, Wu CH, Yao WJ, Yang YC, Wu JS, Lu FH. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. Int J Obes Relat Metab Disord 2000; 24: 1699-704.
13. Gao Q, Horvath TL. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am J Physiol Endocrinol Metab 2008; 294: E817-26.
14. Gomori A, Ishihara A, Ito M, Matsushita H, Ito M, Mashiko S, et al. Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice. Br J Pharmacol 2007; 151: 900-8.
15. Sorensen MB, Rosenfalck AM, Hojgaard L, Ottesen B. Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy. Obes Res 2001; 9: 622-6.
16. Ryan AS, Nicklas BJ, Berman DM. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women. Diabetes Care 2002; 25: 127-33.
17. Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 1998; 128: 285-8.
18. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, et al. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group. Circulation 1993; 88: 2163-71.
19. Brinton LA, Schairer C. Estrogen replacement therapy and breast cancer risk. Epidemiol Rev 1993; 15: 66-79.
20. Burry K, Cain JM. Estrogen replacement therapy and risk of ovarian cancer in postmenopausal women. JAMA 2002; 288: 2538; author reply 2539.
21. Ambrus JL. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism. Am J Med 1999; 107: 104.
22. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-58.
23. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181-9.
24. Nicholson JK, Lindon JC. Systems biology: Metabonomics. Nature 2008; 455: 1054-6.
25. Nicholson JK, Wilson ID. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003; 2: 668-76.
26. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM. Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 2008; 48: 653-83.
27. Saude EJ, Obiefuna IP, Somorjai RL, Ajamian F, Skappak C, Ahmad T, et al. Metabolomic biomarkers in a model of asthma exacerbation: urine nuclear magnetic resonance. Am J Respir Crit Care Med 2009; 179: 25-34.
28. Chen C, Gonzalez FJ, Idle JR. LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 2007; 39: 581-97.
29. Zhang Q, Wang GJ, A JY, Wu D, Zhu LL, Ma B, et al. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats. Acta Pharmacol Sin 2009; 30: 1674-87.
30. Kamleh MA, Hobani Y, Dow JA, Watson DG. Metabolomic profiling of Drosophila using liquid chromatography Fourier transform mass spectrometry. FEBS Lett 2008; 582: 2916-22.
31. Lu Y, A J, Wang G, Hao H, Huang Q, Yan B, et al. Gas chromatography/ time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Rapid Commun Mass Spectrom 2008; 22: 2882-8.
32. Gu S, A J, Wang G, Zha W, Yan B, Zhang Y, et al. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia. Biomed Chromatogr 2010; 24: 245-52.
33. Yan B, A J, Wang G, Lu H, Huang X, Liu Y, et al. Metabolomic investigation into variation of endogenous metabolites in professional athletes subject to strength-endurance training. J Appl Physiol 2009; 106: 531-8.
34. Liu L, Aa J, Wang G, Yan B, Zhang Y, Wang X, et al. Differences in metabolite profile between blood plasma and serum. Anal Biochem 2010; 406: 105-12.
35. A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 2005; 77: 8086-94.
36. Novelli EL, Diniz YS, Galhardi CM, Ebaid GM, Rodrigues HG, Mani F, et al. Anthropometrical parameters and markers of obesity in rats. Lab Anim 2007; 41: 111-9.
37. Von Diemen V, Trindade EN, Trindade MR. Experimental model to induce obesity in rats. Acta Cir Bras 2006; 21: 425-9.
38. Rogers NH, Perfield JW 2nd, Strissel KJ, Obin MS, Greenberg AS. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009; 150: 2161-8.
39. Herrero P, Soto PF, Dence CS, Kisrieva-Ware Z, Delano DA, Peterson LR, et al. Impact of hormone replacement on myocardial fatty acid metabolism: potential role of estrogen. J Nucl Cardiol 2005; 12: 574-81.
40. Kamei Y, Suzuki M, Miyazaki H, Tsuboyama-Kasaoka N, Wu J, Ishimi Y, et al. Ovariectomy in mice decreases lipid metabolism-related gene expression in adipose tissue and skeletal muscle with increased body fat. J Nutr Sci Vitaminol (Tokyo) 2005; 51: 110-7.
41. Wang Y, Sullivan S, Trujillo M, Lee MJ, Schneider SH, Brolin RE, et al. Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot. Obes Res 2003; 11: 930-6.
42. Furman E, Rushkin E, Margalit R, Bendel P, Degani H. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging. J Steroid Biochem Mol Biol 1992; 43: 189-95.
43. McClung JM, Davis JM, Wilson MA, Goldsmith EC, Carson JA. Estrogen status and skeletal muscle recovery from disuse atrophy. J Appl Physiol 2006; 100: 2012-23.
44. Sugiura T, Ito N, Goto K, Naito H, Yoshioka T, Powers SK. Estrogen administration attenuates immobilization-induced skeletal muscle atrophy in male rats. J Physiol Sci 2006; 56: 393-9.
45. Beckett T, Tchernof A, Toth MJ. Effect of ovariectomy and estradiol replacement on skeletal muscle enzyme activity in female rats. Metabolism 2002; 51: 1397-401.
46. Raben A, Mygind E, Astrup A. Lower activity of oxidative key enzymes and smaller fiber areas in skeletal muscle of postobese women. Am J Physiol 1998; 275: E487-94.
47. Nilsen J, Irwin RW, Gallaher TK, Brinton RD. Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci 2007; 27: 14069-77.
48. Mataumoto J, Kishida T, Ebihara K. Sugar beet fiber suppresses ovarian hormone deficiency-induced hypercholesterolemia in rats. Nutr Res 2001; 21: 1519-27.
49. Bagdade JD, Bierman EL, Porte D Jr. Are plasma amino acid levels elevated in obesity. N Engl J Med 1970; 282: 166.
50. Felig P, Marliss E, Cahill GF Jr. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969; 281: 811-6.
51. Leclercq B, Seve B. Influence of adiposity (genetic or hormonal) on the metabolism of amino acids and nutritional responses. Reprod Nutr Dev 1994; 34: 569-82.
52. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ. Obesityrelated elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007; 293: E1552-63.